Diamond Biofund is an evergreen biotech venture capital headquartered in Taipei. The founding shareholders include Microbio Group, Fubon Financial, Taishin Holdings, and Ruentex Group, adhering to the mission of “Supporting Innovation” and “Caring for Life.” We have incubated and invested in more than 20 extraordinary entrepreneurs and companies domestically, regionally and globally, while many of them had successfully entered capital markets.
We specialize in biotechnology and medical investments, with focused areas in new drug research and development, high-end medical equipment, innovative medical service technology, medical channel, and agricultural biotechnology, etc. Diamond Biofund seeks to provide portfolio companies with our insights, network, as well as global resources. We recruit talents from diverse cultures and professions including corporate governance, technology R&D, clinical implementation, business development, capital market, and other disciplines. We strive to accelerate the success of our portfolio companies.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Taipei, Tw
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- diamondbiofund.com
- Keywords
- technology.
- HQ
- Taipei
Diamond Biofund Inc. Questions
Diamond Biofund Inc.'s website is diamondbiofund.com
Diamond Biofund Inc.'s LinkedIn profile is https://tw.linkedin.com/company/diamond-biofund-inc.
Diamond Biofund Inc. has
9 employees.
View email and phone details for 9
employees at Diamond Biofund Inc..
Diamond Biofund Inc.'s industry is
Venture Capital and Private Equity Principals
Diamond Biofund Inc.'s top competitors are
Vivo Capital,
Taiwania Capital,
澳門五洲藥物國際貿易有限公司,
Oneness Biotech Co Ltd,
Stemcyte Inc.,
Benhealth,
Alira Health,
Tmu Biomed Accelerator,
Microbio Co Ltd,
Taitra Global (Taiwan External Trade Development Council).
Diamond Biofund Inc.'s categories are Venture Capital and Private Equity Principals
Diamond Biofund Inc.'s founding year is 2013
